Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 123,911 | 110,524 | 116,682 | 104,780 | 111,172 |
| Cost of Goods | 22,657 | 20,243 | 20,965 | 23,549 | 21,007 |
| Gross Profit | 101,254 | 90,281 | 95,717 | 81,231 | 90,165 |
| Operating Expenses | 84,007 | 89,266 | 87,021 | 86,094 | 116,744 |
| Operating Income | 17,904 | 1,258 | 9,661 | -4,314 | -26,572 |
| Interest Expense | 20,537 | 20,307 | 20,148 | 22,727 | 22,702 |
| Other Income | 175 | 113 | -5,710 | 130 | 419 |
| Pre-tax Income | -2,458 | -18,936 | -16,197 | -26,911 | -48,855 |
| Income Tax | 41,910 | -6,042 | -5,656 | -5,994 | -18,188 |
| Net Income Continuous | -44,368 | -12,894 | -10,541 | -20,917 | -30,667 |
| Net Income | $-44,368 | $-12,894 | $-10,541 | $-20,917 | $-30,667 |
| EPS Basic Total Ops | -2.92 | -0.84 | -0.68 | -1.36 | -2.00 |
| EPS Basic Continuous Ops | -2.89 | -0.84 | -0.69 | -1.37 | -2.03 |
| EPS Diluted Total Ops | -2.92 | -0.84 | -0.68 | -1.36 | -2.00 |
| EPS Diluted Continuous Ops | -2.89 | -0.84 | -0.69 | -1.37 | -2.03 |
| EBITDA(a) | $48,849 | $33,401 | $41,718 | $27,589 | $5,408 |